Utah Medical Products, Inc. (UTMD) Earnings History
Profitable37 years of earnings data (1989–2025) · Positive TTM net income
Loading earnings history...
Utah Medical Products, Inc. (UTMD) Earnings Overview
As of June 23, 2026, Utah Medical Products, Inc. (UTMD) reported trailing twelve-month net income of $11M, reflecting -12.1% year-over-year growth. The company earned $3.53 per diluted share over the past four quarters, with a net profit margin of 29.3%.
Looking at the long-term picture, UTMD's 5-year EPS compound annual growth rate (CAGR) stands at +3.4%, reflecting modest earnings expansion. The company achieved its highest annual net income of $21M in fiscal 2003.
Utah Medical Products, Inc. maintains industry-leading profitability with a gross margin of 51.6%, operating margin of 29.6%, and net margin of 29.3%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including NVCR (-$173M net income, -20.8% margin), MMSI ($139M net income, 8.5% margin), LMAT ($62M net income, 23.1% margin), UTMD has outperformed on profitability metrics. Compare UTMD vs NVCR →
UTMD Earnings vs Peers
Earnings metrics vs comparable public companies
UTMD Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $11M | -18.7% | $11M | $3.48 | 29.3% | 29.6% |
| 2024 | $14M | -16.6% | $14M | $3.96 | 33.9% | 33.2% |
| 2023 | $17M | +1.0% | $17M | $4.57 | 33.1% | 33.4% |
| 2022 | $16M | +11.4% | $20M | $4.52 | 31.5% | 37.9% |
| 2021 | $15M | +37.0% | $19M | $4.04 | 30.1% | 38.5% |
| 2020 | $11M | -26.7% | $14M | $2.94 | 25.6% | 32.5% |
| 2019 | $15M | -20.6% | $18M | $3.94 | 31.4% | 37.6% |
| 2018 | $19M | +118.2% | $19M | $4.95 | 44.2% | 44.5% |
| 2017 | $9M | -29.9% | $19M | $2.28 | 20.5% | 45.9% |
| 2016 | $12M | +2.4% | $16M | $3.22 | 30.9% | 41.2% |
| 2015 | $12M | +4.1% | $16M | $3.14 | 29.5% | 39.0% |
| 2014 | $11M | -0.2% | $16M | $3.01 | 27.6% | 39.3% |
| 2013 | $11M | +12.2% | $15M | $3.02 | 28.2% | 36.6% |
| 2012 | $10M | +37.2% | $15M | $2.74 | 24.5% | 36.6% |
| 2011 | $7M | +23.3% | $12M | $2.03 | 19.6% | 31.3% |
| 2010 | $6M | -3.9% | $9M | $1.65 | 23.9% | 35.5% |
| 2009 | $6M | -13.1% | $9M | $1.72 | 24.1% | 36.4% |
| 2008 | $7M | -8.9% | $10M | $1.86 | 25.9% | 37.4% |
| 2007 | $8M | -3.2% | $11M | $1.98 | 27.7% | 37.7% |
| 2006 | $8M | +8.2% | $11M | $2.02 | 28.4% | 37.7% |
| 2005 | $8M | -26.2% | $9M | $1.80 | 27.3% | 33.4% |
| 2004 | $10M | -50.8% | $15M | $2.19 | 38.6% | 57.8% |
| 2003 | $21M | +189.8% | $11M | $4.25 | 76.5% | 39.5% |
| 2002 | $7M | +20.7% | $11M | $1.36 | 26.2% | 38.5% |
| 2001 | $6M | +10.4% | $9M | $1.14 | 22.0% | 34.4% |
| 2000 | $5M | -1.7% | $8M | $0.90 | 19.8% | 30.8% |
| 1999 | $5M | +11.6% | $8M | $0.76 | 18.6% | 28.1% |
| 1998 | $5M | +14.0% | $7M | $0.59 | 17.7% | 24.2% |
| 1997 | $4M | -51.1% | $6M | $0.51 | 17.7% | 22.6% |
| 1996 | $9M | +4.8% | $12M | $0.93 | 22.7% | 30.7% |
| 1995 | $8M | +18.3% | $12M | $0.82 | 20.0% | 27.9% |
| 1994 | $7M | +1.4% | $10M | $0.68 | 17.9% | 25.3% |
| 1993 | $7M | +1.4% | $9M | $0.60 | 18.9% | 24.1% |
| 1992 | $7M | +27.8% | $9M | $0.57 | 19.1% | 26.0% |
| 1991 | $5M | +25.6% | $8M | $0.46 | 18.1% | 26.8% |
| 1990 | $4M | +65.4% | $6M | $0.37 | 18.0% | 25.1% |
| 1989 | $3M | - | $4M | $0.23 | 14.5% | 21.8% |
Download Data
Export UTMD earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
37+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
UTMD — Frequently Asked Questions
Quick answers to the most common questions about buying UTMD stock.
What is UTMD earnings per share (EPS)?
UTMD trailing twelve-month (TTM) diluted EPS is $3.53, reflecting -12.1% year-over-year growth. The 5-year EPS CAGR is +3.4%. Complete EPS history from 1989 to 2025 is available in the table on this page.
What is Utah Medical Products, Inc.'s net income?
Utah Medical Products, Inc. (UTMD) trailing twelve-month net income is $11M as of 2025. Earnings declined -12.1% year-over-year. Utah Medical Products, Inc. has been profitable for 37 consecutive years.
Is UTMD profitable?
Yes, UTMD is profitable with a TTM net income of $11M and a net profit margin of +29.3%. Utah Medical Products, Inc. has generated profits for 37 consecutive years.
What is UTMD's earnings growth rate?
UTMD compound annual EPS growth rates (CAGR): 1-Year: -12.1%, 3-Year: -8.3%, 5-Year: +3.4%, 10-Year: +1.0%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1989 to 2025.
What are UTMD's profit margins?
Utah Medical Products, Inc. net profit margin is +29.3%, operating margin is +29.6%, and gross margin is +51.6%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +9.5%.
Is UTMD growing earnings?
UTMD earnings are declining — EPS fell -12.1% year-over-year. TTM net income dropped to $11M. This contrasts with the 5-year CAGR of +3.4%.
What was UTMD's best earnings year?
Utah Medical Products, Inc.'s highest annual net income on record is $21M, achieved in fiscal year 2003. Earnings history on this page spans 1989 to 2025 and includes all annual and quarterly figures.
What were UTMD's earnings last quarter?
UTMD's most recent reported quarter was Q4 2025. Net income was $3M with diluted EPS of $0.80. For a full breakdown of all quarters, see the quarterly earnings table on this page.